Biotest Aktiengesellschaft (ETR:BIO - Get Free Report)'s stock price shot up 4.9% during mid-day trading on Wednesday . The stock traded as high as €42.80 ($47.03) and last traded at €42.80 ($47.03). 350 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 1,927 shares. The stock had previously closed at €40.80 ($44.84).
Biotest Aktiengesellschaft Stock Performance
The business has a 50 day simple moving average of €41.20 and a 200-day simple moving average of €41.44. The firm has a market capitalization of $843.05 million, a price-to-earnings ratio of 10.27 and a beta of 0.24.
Biotest Aktiengesellschaft Company Profile
(
Get Free Report)
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Read More
Before you consider Biotest Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Biotest Aktiengesellschaft wasn't on the list.
While Biotest Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
